These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 7110103

  • 1. Sjögren's syndrome: autoimmune exocrinopathy.
    Reinertsen JL.
    Minn Med; 1982 Jun; 65(6):363-4. PubMed ID: 7110103
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Restructuration of the Gougerot-Sjögren syndrome].
    Escande JP.
    Nouv Presse Med; 1972 Mar 18; 1(12):785-9. PubMed ID: 5015455
    [No Abstract] [Full Text] [Related]

  • 5. An alternative perspective to the immune response in autoimmune exocrinopathy: induction of functional quiescence rather than destructive autoaggression.
    Humphreys-Beher MG, Brayer J, Yamachika S, Peck AB, Jonsson R.
    Scand J Immunol; 1999 Jan 18; 49(1):7-10. PubMed ID: 10023850
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Sjögren's syndrome (autoimmune exocrinopathy)].
    Stroffolini FA, Palomba F, Menditti D, Labella R.
    Arch Stomatol (Napoli); 1988 Dec 18; 29(6):1283-316. PubMed ID: 3274626
    [No Abstract] [Full Text] [Related]

  • 9. Recent developments in the immunology of Sjögren's syndrome (autoimmune exocrinopathy).
    Talal N.
    Scand J Rheumatol Suppl; 1986 Dec 18; 61():76-82. PubMed ID: 3296158
    [No Abstract] [Full Text] [Related]

  • 10. Immunotherapeutic targets in estrogen deficiency-dependent Sjögren's syndrome-related manifestations.
    Arakaki R, Ishimaru N, Hayashi Y.
    Immunotherapy; 2010 May 18; 2(3):339-46. PubMed ID: 20635899
    [Abstract] [Full Text] [Related]

  • 11. Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatment.
    Lodde BM, Baum BJ, Tak PP, Illei G.
    Ann Rheum Dis; 2006 Nov 18; 65(11):1406-13. PubMed ID: 16880196
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sjögren's syndrome. Yes autoreactive lymphocytes, why? Virus or gene?
    Sawada S, Takei M.
    Intern Med; 2002 Feb 18; 41(2):75-6. PubMed ID: 11868610
    [No Abstract] [Full Text] [Related]

  • 20. Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias.
    Tzioufas AG, Voulgarelis M.
    Best Pract Res Clin Rheumatol; 2007 Dec 18; 21(6):989-1010. PubMed ID: 18068857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.